ClinicalTrials.Veeva
Menu

Find clinical trials for Pancreatic Cancer in Taipei City

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Adenocarcinoma
Cancer
Carcinoma
Colorectal Cancer
Non-Small-Cell Lung Carcinoma
Lung Cancer
Squamous Cell Carcinoma of Head and Neck

Pancreatic Cancer trials near Taipei City, TWN:

MS-20 on Gut Microbiota and Risk/Severity of Cachexia in Pancreatic Cancer Patients

Cachexia has been recognized as a direct cause of reduced quality of life complicating in cancer patients. Patients with pancreatic ...

Enrolling
Pancreatic Cancer
Chemotherapy Effect
Drug: MS-20
Other: Placebo
National Taiwan University
National Taiwan University

Taipei, Taiwan

Antroquinonol is proposed for the treatment of neoplasms. The proposed clinical trial is a Phase I/II study designed to evaluate antroquinon ...

Active, not recruiting
Pancreatic Neoplasm
Drug: Antroquinonol

Phase 1, Phase 2

Golden Biotechnology

Taipei, Taiwan and 8 other locations

Zolbetuximab is being studied as a treatment for people with pancreatic cancer. Most people with pancreatic cancer...

Active, not recruiting
Metastatic Pancreatic Adenocarcinoma
Metastatic Pancreatic Cancer
Drug: nab-paclitaxel
Drug: gemcitabine

Phase 2

Astellas
Astellas

Taipei City, Taiwan and 135 other locations

phosphorylase (MTAP)-deleted gastrointestinal, biliary tract, or pancreatic cancers. The study also aims to determine the safety pr...

Enrolling
Advanced Gastrointestinal, Biliary Tract, and Pancreatic Cancers
Drug: Gemcitabine
Drug: AMG 193

Phase 1

Amgen
Amgen

Taipei, Taiwan and 44 other locations

to assess the safety, tolerability, PK, PD, immunogenicity and anti-tumor activity of zenocutuzumab (MCLA-128) in patients with solid tumors...

Enrolling
Pancreatic Cancer Harboring NRG1 Fusion
NSCLC Harboring NRG1 Fusion
Drug: zenocutuzumab (MCLA-128)

Phase 2

Merus

Taipei, Taiwan and 64 other locations

This is an open-label, multicenter, global Phase 2 basket study of entrectinib (RXDX-101) for the treatment of patients with solid tumors th...

Active, not recruiting
Breast Cancer
Neuroendocrine Tumors
Drug: Entrectinib

Phase 2

Roche
Roche

Taipei City, Taiwan and 122 other locations

of AZD0901 as monotherapy and in combination with anti-cancer agents in participants with locally advanced unresectable or metastatic solid ...

Enrolling
Gastroesophageal Junction Cancer
Gastric Cancer
Drug: l-leucovorin
Drug: Gemcitabine

Phase 2

AstraZeneca
AstraZeneca

Taipei City, Taiwan and 48 other locations

This study is open to adults with advanced cancer in the biliary tract, pancreas, lung, or bladder. This is a study for people for ...

Enrolling
Lung Neoplasms
Bladder Cancer
Drug: brigimadlin

Phase 2

Boehringer Ingelheim
Boehringer Ingelheim

Taipei, Taiwan and 66 other locations

This is a proof-of-concept study designed to investigate HER3-DXd monotherapy in locally advanced or metastatic solid tumors. The study is e...

Enrolling
Endometrial Cancer
Bladder Cancer
Drug: HER3-DXd

Phase 2

Daiichi Sankyo
Daiichi Sankyo

Taipei, Taiwan and 9 other locations

This is a Phase 2, multicenter, open-label, 3-arm, randomized, parallel group study to evaluate the efficacy and safety of TTX-030 with or without bu...

Enrolling
Pancreatic Cancer
Combination Product: TTX-030, nab-paclitaxel and gemcitabine
Combination Product: TTX-030, budigalimab, nab-paclitaxel and gemcitabine

Phase 2

Trishula Therapeutics

Taipei, Taiwan and 64 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems